SK
Shashi Shekhar Kumar
Also known as: Shashi Shekhar
Irving Medical Center, Columbia University, National Brain Research Centre, University of Hyderabad School of Life Sciences, Patna Science College, Patna University
0000-0003-1077-407X
Employment
-
Irving Medical Center, Columbia University Associate Research Scientist2021 - Present
Education
-
National Brain Research Centre Ph.D.2012 - 2020
-
University of Hyderabad School of Life Sciences M. Sc. Animal Biotechnology2010 - 2012
-
Patna Science College, Patna University B. Sc. Biotechnology (H)2007 - 2010
Projects & Funding
Projects & funding information is unavailable.
Publications (12)
- Correction to “Sugar-Terminated Nanoparticle Chaperones Are 102–105 Times Better Than Molecular Sugars in Inhibiting Protein Aggregation and Reducing Amyloidogenic Cytotoxicity” Save
- Dietary restriction improves proteostasis and increases life span through endoplasmic reticulum hormesis. Save
- Down-Regulation of miRNA-708 Promotes Aberrant Calcium Signaling by Targeting Neuronatin in a Mouse Model of Angelman Syndrome. Save
- Azadiradione Restores Protein Quality Control and Ameliorates the Disease Pathogenesis in a Mouse Model of Huntington’s Disease Save
- Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer’s disease Save
- Rescue of altered HDAC activity recovers behavioural abnormalities in a mouse model of Angelman syndrome Save
- S-nitrosylation of UCHL1 induces its structural instability and promotes α-synuclein aggregation. Save
- Sugar-Terminated Nanoparticle Chaperones are 102-105 Times Better than Molecular Sugars in Inhibiting Protein Aggregation and Lowering of Amyloidogenic Cytotoxicity. Save
- Topoisomerase 1 inhibitor topotecan delays the disease progression in a mouse model of Huntington's disease. Save
- Environmental Enrichment Improves Behavioral Abnormalities in a Mouse Model of Angelman Syndrome. Save